SlideShare a Scribd company logo
1 of 31
  National HIV Prevention , Care and Treatment Program  Adherence Technical Meeting  October 19 th  - 22 nd , 2009 Jules Mugabo M.D HIV, AIDS and STI Unit TRAC Plus/ Rwanda MOH TRAC  Plus  C enter for  T reatment and  R esearch  on  A IDS,  M alaria,  T uberculosis and  O ther  E pidemics
HIV Prevention Program ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
VCT National program 2004-2008 2004 2005 2006 2007 2008 Estimation of general population (census 2002) 8,577,753 8,814,253 9,058,392 9,309,619 9,567,190 Targeted population for VCT (50% of the general population) 4,288,877 4,407,127 4,529,196 4,654,810 4,783,595 % Of clients tested (denominator:  Targeted population for VCT) 4.1% 10.2% 10.4% 16.1% 20.2% HIV seroprevalence in VCT 11.4% 9.4% 7.3% 4.8% 3.4% % of Health facilities offering VCT 26.5% 46.2% 51.8% 63.1% 75.4%
PMTCT Program 2004-2008 2004 2005 2006 2007 2008 Rwanda population (census 2002) 8,577,753 8,814,253 9,058,392 9,309,619 9,567,190 Expected pregnant women 351,688 361,384 371,394 381,694 392,255 % of pregnant women tested for HIV 27% 49% 59% 56% 75% % of HIV + women receiving ART prophylaxis 35% 51% 60% 55% 67% % of exposed children receiving ART prophylaxis 26% 33% 46% 65% 63% % of partners tested for HIV in PMTCT ND 32,6% 52,4% 65% 78% % of discordant couples in PMTCT ND 4,5% 3,7% 3,1% 2,7% % of Health facilities providing PMTCT 26.5% 46.2% 51.8% 63.1% 75.4%
Level of participation in PMTCT program
Rate of MTCT of HIV
Barriers to PMTCT use ,[object Object],[object Object],[object Object],[object Object]
Barriers to PMTCT use ,[object Object],[object Object],[object Object],[object Object]
Reasons for less adherence of  pregnant women to PMTCT services  ,[object Object],[object Object],[object Object]
PMTCT clients challenges and program weakness ,[object Object],[object Object],[object Object]
HIV Care and Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ART Program 2004-2008 2004 2005 2006 2007 2008 Estimation of general population (census 2002) 8,577,753 8,814,253 9,058,392 9,309,619 9,567,190 Adults HIV+ adult (15+) 158,275 157,157 162,837 170,639 177,258 Adults in need of ARVs 50,106 48,733 49,316 52,949 92,421 Proportion of eligible adults receiving ART 18% 36% 64% 80% 62% Children HIV+ children (0-14) 29,373 29,621 29,878 30,275 31,299 Infants in need of ARVs 7,625 7,395 7,517 7,912 8,544 Proportion of eligible children receiving ART 7% 20% 37% 55% 66% Services coverage % of Health facilities offering 7% 18% 29% 36% 43%
Patients on ART end June 2009 = 70,234  patients) ARV regimen % patients  96.58 %  of adults  patients  D4T+3TC+NVP 48.07 AZT+3TC+NVP 34.82 D4T+3TC+EFV 5.40 AZT+3TC+EFV 8.29 Type of health facility Children Adults Hospital 37.3% 36.5% Health center 62.7% 63.5% Total 100%  100% 
Evaluation of Clinical and Immunologic  Outcomes from the National ART Program ,[object Object],[object Object],[object Object],[object Object]
Evaluation of Clinical and Immunologic Outcomes from the National ART Program ,[object Object],[object Object],[object Object]
Evaluation of Clinical and Immunologic Outcomes from the National ART Program ,[object Object],[object Object],[object Object]
Evaluation of Clinical and Immunologic Outcomes from the National ART Program ,[object Object],[object Object],[object Object],[object Object],[object Object]
  100% self-reported adherence during 3 and 30  days
Outcome: Self-reported adherence:  30-day recall  N=575 N=490 N=352
Current viral load
Timing of missed pills among patients reporting ≤100% adherence in 3 days preceding interview
Most common reasons for ever missing ART
Patient’s level factors  predicting  self-reported 30-day non-adherence  …
Patient’s level factors  predicting  self-reported 30-day non-adherence …
Patient’s level factors  predicting  self-reported 30-day non-adherence …
Facility level factors  predicting  self-reported 30-day non-adherence  …
Perspectives ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object]

More Related Content

What's hot

Pmtct programme summary
Pmtct programme summaryPmtct programme summary
Pmtct programme summary
gaylemclennan
 
03 Hadebe I.M 5 Th Sahara Conference Pmtc
03 Hadebe I.M 5 Th Sahara Conference Pmtc03 Hadebe I.M 5 Th Sahara Conference Pmtc
03 Hadebe I.M 5 Th Sahara Conference Pmtc
Nicholas Jacobs
 

What's hot (20)

Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...
Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...
Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...
 
HIV self-testing among transgender women in San Francisco - a pilot
HIV self-testing among transgender women in San Francisco - a pilotHIV self-testing among transgender women in San Francisco - a pilot
HIV self-testing among transgender women in San Francisco - a pilot
 
Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...
Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...
Evolving Switch Strategies for Virologically Suppressed HIV-Infected Patients...
 
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
 
09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals
 
Vaccine safety
Vaccine safetyVaccine safety
Vaccine safety
 
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
 
Midterm Outcome Evaluation of Government-Led Endeavors to Eliminate Hepatitis...
Midterm Outcome Evaluation of Government-Led Endeavors to Eliminate Hepatitis...Midterm Outcome Evaluation of Government-Led Endeavors to Eliminate Hepatitis...
Midterm Outcome Evaluation of Government-Led Endeavors to Eliminate Hepatitis...
 
Facilitating self management of chronic disease through home based tele monit...
Facilitating self management of chronic disease through home based tele monit...Facilitating self management of chronic disease through home based tele monit...
Facilitating self management of chronic disease through home based tele monit...
 
HIV self-testing in MSM
HIV self-testing in MSMHIV self-testing in MSM
HIV self-testing in MSM
 
Let's Talk Lymphedema
Let's Talk LymphedemaLet's Talk Lymphedema
Let's Talk Lymphedema
 
Pmtct programme summary
Pmtct programme summaryPmtct programme summary
Pmtct programme summary
 
Lessons learned from Brazil on HIV self-testing and pre-exposure prophylaxis
Lessons learned from Brazil on HIV self-testing and pre-exposure prophylaxisLessons learned from Brazil on HIV self-testing and pre-exposure prophylaxis
Lessons learned from Brazil on HIV self-testing and pre-exposure prophylaxis
 
Γιώτα Τουλούμη, 6th Clinical Research Conference
Γιώτα Τουλούμη, 6th Clinical Research ConferenceΓιώτα Τουλούμη, 6th Clinical Research Conference
Γιώτα Τουλούμη, 6th Clinical Research Conference
 
Updated guidelines on COVID-19 vaccination for pregnant and breastfeeding mot...
Updated guidelines on COVID-19 vaccination for pregnant and breastfeeding mot...Updated guidelines on COVID-19 vaccination for pregnant and breastfeeding mot...
Updated guidelines on COVID-19 vaccination for pregnant and breastfeeding mot...
 
Clinical Genomics and Medicine
Clinical Genomics and MedicineClinical Genomics and Medicine
Clinical Genomics and Medicine
 
03 Hadebe I.M 5 Th Sahara Conference Pmtc
03 Hadebe I.M 5 Th Sahara Conference Pmtc03 Hadebe I.M 5 Th Sahara Conference Pmtc
03 Hadebe I.M 5 Th Sahara Conference Pmtc
 
Νικόλαος Τσούλος, MedTech Conference 2021
Νικόλαος Τσούλος, MedTech Conference 2021Νικόλαος Τσούλος, MedTech Conference 2021
Νικόλαος Τσούλος, MedTech Conference 2021
 
The global challenge of patient safety
The global challenge of patient safetyThe global challenge of patient safety
The global challenge of patient safety
 
HCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel PeckHCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel Peck
 

Viewers also liked

Viewers also liked (6)

Publicité mobile: toujours au plus proche des utilisateurs
Publicité mobile: toujours au plus proche des utilisateursPublicité mobile: toujours au plus proche des utilisateurs
Publicité mobile: toujours au plus proche des utilisateurs
 
Lancement du format video 2011 sofialys
Lancement du format video 2011 sofialysLancement du format video 2011 sofialys
Lancement du format video 2011 sofialys
 
Net app
Net app Net app
Net app
 
A7
A7A7
A7
 
Présentation Numbate « Les français et la publicité mobile »
Présentation Numbate « Les français et la publicité mobile »Présentation Numbate « Les français et la publicité mobile »
Présentation Numbate « Les français et la publicité mobile »
 
約1000サービスの実績から見えた「UXを可視化するユーザーテストの極意」 先生:平石 大祐
約1000サービスの実績から見えた「UXを可視化するユーザーテストの極意」  先生:平石 大祐約1000サービスの実績から見えた「UXを可視化するユーザーテストの極意」  先生:平石 大祐
約1000サービスの実績から見えた「UXを可視化するユーザーテストの極意」 先生:平石 大祐
 

Similar to Presentation: Results of National Adherence PHE

Adherence to PMTCT: Plenary
Adherence to PMTCT: PlenaryAdherence to PMTCT: Plenary
Adherence to PMTCT: Plenary
icapclinical
 
IATT-Framework-May-2015
IATT-Framework-May-2015IATT-Framework-May-2015
IATT-Framework-May-2015
Jack Menke
 
The journey towards making elimination of mother to child transmission a real...
The journey towards making elimination of mother to child transmission a real...The journey towards making elimination of mother to child transmission a real...
The journey towards making elimination of mother to child transmission a real...
HopkinsCFAR
 
World medical tourism and global health conference providing low cost child h...
World medical tourism and global health conference providing low cost child h...World medical tourism and global health conference providing low cost child h...
World medical tourism and global health conference providing low cost child h...
Gordon Otieno Odundo
 
Addressing the Gaps in PMTCT Care - A Dr Besser Presentation
Addressing the Gaps in PMTCT Care - A Dr Besser PresentationAddressing the Gaps in PMTCT Care - A Dr Besser Presentation
Addressing the Gaps in PMTCT Care - A Dr Besser Presentation
mothers2mothers
 

Similar to Presentation: Results of National Adherence PHE (20)

WGHA Discovery Series: Cathering Wilfert
WGHA Discovery Series: Cathering WilfertWGHA Discovery Series: Cathering Wilfert
WGHA Discovery Series: Cathering Wilfert
 
Современное лечение ВИЧ.Объединенные данные с конференции IAS 2019 / Contemp...
Современное лечение ВИЧ.Объединенные данные с конференции  IAS 2019 / Contemp...Современное лечение ВИЧ.Объединенные данные с конференции  IAS 2019 / Contemp...
Современное лечение ВИЧ.Объединенные данные с конференции IAS 2019 / Contemp...
 
Adherence to PMTCT: Plenary
Adherence to PMTCT: PlenaryAdherence to PMTCT: Plenary
Adherence to PMTCT: Plenary
 
IATT-Framework-May-2015
IATT-Framework-May-2015IATT-Framework-May-2015
IATT-Framework-May-2015
 
Better Diagnostics Are Needed to Achieve an AIDS-Free Generation
Better Diagnostics Are Needed to Achieve an AIDS-Free GenerationBetter Diagnostics Are Needed to Achieve an AIDS-Free Generation
Better Diagnostics Are Needed to Achieve an AIDS-Free Generation
 
DGH Lecture Series: Michael Chung
DGH Lecture Series: Michael ChungDGH Lecture Series: Michael Chung
DGH Lecture Series: Michael Chung
 
PMTCT of HIV and MTCT plus
PMTCT of HIV and MTCT plusPMTCT of HIV and MTCT plus
PMTCT of HIV and MTCT plus
 
Ijsrp p8825 Caregiver factors influencing seeking of Early Infant Diagnosis (...
Ijsrp p8825 Caregiver factors influencing seeking of Early Infant Diagnosis (...Ijsrp p8825 Caregiver factors influencing seeking of Early Infant Diagnosis (...
Ijsrp p8825 Caregiver factors influencing seeking of Early Infant Diagnosis (...
 
Immunisation Excellence Seminar
Immunisation Excellence SeminarImmunisation Excellence Seminar
Immunisation Excellence Seminar
 
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...Hepatitis C elimination in HIV-infected men who have sex with men: reality an...
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...
 
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
 
Community Based Treatment Support Services: The Treatment Support Arm of the ...
Community Based Treatment Support Services: The Treatment Support Arm of the ...Community Based Treatment Support Services: The Treatment Support Arm of the ...
Community Based Treatment Support Services: The Treatment Support Arm of the ...
 
The journey towards making elimination of mother to child transmission a real...
The journey towards making elimination of mother to child transmission a real...The journey towards making elimination of mother to child transmission a real...
The journey towards making elimination of mother to child transmission a real...
 
Neil Dugdale sobi crdn summit 2017
Neil Dugdale sobi crdn summit 2017Neil Dugdale sobi crdn summit 2017
Neil Dugdale sobi crdn summit 2017
 
Using Data to Improve LTC - Debbie Wendell
Using Data to Improve LTC -  Debbie WendellUsing Data to Improve LTC -  Debbie Wendell
Using Data to Improve LTC - Debbie Wendell
 
Using Data to Improve Linkage to Care
Using Data to Improve Linkage to CareUsing Data to Improve Linkage to Care
Using Data to Improve Linkage to Care
 
World medical tourism and global health conference providing low cost child h...
World medical tourism and global health conference providing low cost child h...World medical tourism and global health conference providing low cost child h...
World medical tourism and global health conference providing low cost child h...
 
IJMPR43122-515-529.docx
IJMPR43122-515-529.docxIJMPR43122-515-529.docx
IJMPR43122-515-529.docx
 
Increasing Coverage & Quality of PMTCT Services Beyond 2010
Increasing Coverage & Quality of PMTCT Services Beyond 2010Increasing Coverage & Quality of PMTCT Services Beyond 2010
Increasing Coverage & Quality of PMTCT Services Beyond 2010
 
Addressing the Gaps in PMTCT Care - A Dr Besser Presentation
Addressing the Gaps in PMTCT Care - A Dr Besser PresentationAddressing the Gaps in PMTCT Care - A Dr Besser Presentation
Addressing the Gaps in PMTCT Care - A Dr Besser Presentation
 

More from icapclinical

Workshop Goals and Objectives
Workshop Goals and ObjectivesWorkshop Goals and Objectives
Workshop Goals and Objectives
icapclinical
 
Adherence for Pediatrics: Plenary
Adherence for Pediatrics: PlenaryAdherence for Pediatrics: Plenary
Adherence for Pediatrics: Plenary
icapclinical
 
Ethiopia Pediatric Presentation
Ethiopia Pediatric PresentationEthiopia Pediatric Presentation
Ethiopia Pediatric Presentation
icapclinical
 
Assessing Adherence to Treatment: A Partnership
Assessing Adherence to Treatment: A PartnershipAssessing Adherence to Treatment: A Partnership
Assessing Adherence to Treatment: A Partnership
icapclinical
 
Assessing Adherence to Treatment: A Partnership
Assessing Adherence to Treatment: A PartnershipAssessing Adherence to Treatment: A Partnership
Assessing Adherence to Treatment: A Partnership
icapclinical
 
Peer Educators for Adherence, Referral, and Linkages: The ICAP Rwanda Model
Peer Educators for Adherence, Referral, and Linkages: The ICAP Rwanda ModelPeer Educators for Adherence, Referral, and Linkages: The ICAP Rwanda Model
Peer Educators for Adherence, Referral, and Linkages: The ICAP Rwanda Model
icapclinical
 
GIPA/MIPA in ICAP-Tanzania
GIPA/MIPA in ICAP-TanzaniaGIPA/MIPA in ICAP-Tanzania
GIPA/MIPA in ICAP-Tanzania
icapclinical
 
GIPA/MIPA Principles and Adherence Support Programs
GIPA/MIPA Principles and Adherence Support ProgramsGIPA/MIPA Principles and Adherence Support Programs
GIPA/MIPA Principles and Adherence Support Programs
icapclinical
 
Opportunities and Challenges to Adherence: A Field Experience
Opportunities and Challenges to Adherence: A Field ExperienceOpportunities and Challenges to Adherence: A Field Experience
Opportunities and Challenges to Adherence: A Field Experience
icapclinical
 
The Role of the Pharmacy in Adherence Support
The Role of the Pharmacy in Adherence SupportThe Role of the Pharmacy in Adherence Support
The Role of the Pharmacy in Adherence Support
icapclinical
 
Clinical Systems Mentorship and Adherence: The ICAP Approach
Clinical Systems Mentorship and Adherence: The ICAP ApproachClinical Systems Mentorship and Adherence: The ICAP Approach
Clinical Systems Mentorship and Adherence: The ICAP Approach
icapclinical
 
Sustainable Adherence Workshop: Goals & Objectives
Sustainable Adherence Workshop: Goals & ObjectivesSustainable Adherence Workshop: Goals & Objectives
Sustainable Adherence Workshop: Goals & Objectives
icapclinical
 
What Do We Know About Adherence in ICAP Programs?: A Review of the Data
What Do We Know About Adherence in ICAP Programs?: A Review of the DataWhat Do We Know About Adherence in ICAP Programs?: A Review of the Data
What Do We Know About Adherence in ICAP Programs?: A Review of the Data
icapclinical
 
Keynote – Framing Sustainable Adherence to HIV Prevention, Care & Treatment: ...
Keynote – Framing Sustainable Adherence to HIV Prevention, Care & Treatment: ...Keynote – Framing Sustainable Adherence to HIV Prevention, Care & Treatment: ...
Keynote – Framing Sustainable Adherence to HIV Prevention, Care & Treatment: ...
icapclinical
 
APS and Measurement (ICAP Annual Meeting 2007)
APS and Measurement (ICAP Annual Meeting 2007)APS and Measurement (ICAP Annual Meeting 2007)
APS and Measurement (ICAP Annual Meeting 2007)
icapclinical
 

More from icapclinical (15)

Workshop Goals and Objectives
Workshop Goals and ObjectivesWorkshop Goals and Objectives
Workshop Goals and Objectives
 
Adherence for Pediatrics: Plenary
Adherence for Pediatrics: PlenaryAdherence for Pediatrics: Plenary
Adherence for Pediatrics: Plenary
 
Ethiopia Pediatric Presentation
Ethiopia Pediatric PresentationEthiopia Pediatric Presentation
Ethiopia Pediatric Presentation
 
Assessing Adherence to Treatment: A Partnership
Assessing Adherence to Treatment: A PartnershipAssessing Adherence to Treatment: A Partnership
Assessing Adherence to Treatment: A Partnership
 
Assessing Adherence to Treatment: A Partnership
Assessing Adherence to Treatment: A PartnershipAssessing Adherence to Treatment: A Partnership
Assessing Adherence to Treatment: A Partnership
 
Peer Educators for Adherence, Referral, and Linkages: The ICAP Rwanda Model
Peer Educators for Adherence, Referral, and Linkages: The ICAP Rwanda ModelPeer Educators for Adherence, Referral, and Linkages: The ICAP Rwanda Model
Peer Educators for Adherence, Referral, and Linkages: The ICAP Rwanda Model
 
GIPA/MIPA in ICAP-Tanzania
GIPA/MIPA in ICAP-TanzaniaGIPA/MIPA in ICAP-Tanzania
GIPA/MIPA in ICAP-Tanzania
 
GIPA/MIPA Principles and Adherence Support Programs
GIPA/MIPA Principles and Adherence Support ProgramsGIPA/MIPA Principles and Adherence Support Programs
GIPA/MIPA Principles and Adherence Support Programs
 
Opportunities and Challenges to Adherence: A Field Experience
Opportunities and Challenges to Adherence: A Field ExperienceOpportunities and Challenges to Adherence: A Field Experience
Opportunities and Challenges to Adherence: A Field Experience
 
The Role of the Pharmacy in Adherence Support
The Role of the Pharmacy in Adherence SupportThe Role of the Pharmacy in Adherence Support
The Role of the Pharmacy in Adherence Support
 
Clinical Systems Mentorship and Adherence: The ICAP Approach
Clinical Systems Mentorship and Adherence: The ICAP ApproachClinical Systems Mentorship and Adherence: The ICAP Approach
Clinical Systems Mentorship and Adherence: The ICAP Approach
 
Sustainable Adherence Workshop: Goals & Objectives
Sustainable Adherence Workshop: Goals & ObjectivesSustainable Adherence Workshop: Goals & Objectives
Sustainable Adherence Workshop: Goals & Objectives
 
What Do We Know About Adherence in ICAP Programs?: A Review of the Data
What Do We Know About Adherence in ICAP Programs?: A Review of the DataWhat Do We Know About Adherence in ICAP Programs?: A Review of the Data
What Do We Know About Adherence in ICAP Programs?: A Review of the Data
 
Keynote – Framing Sustainable Adherence to HIV Prevention, Care & Treatment: ...
Keynote – Framing Sustainable Adherence to HIV Prevention, Care & Treatment: ...Keynote – Framing Sustainable Adherence to HIV Prevention, Care & Treatment: ...
Keynote – Framing Sustainable Adherence to HIV Prevention, Care & Treatment: ...
 
APS and Measurement (ICAP Annual Meeting 2007)
APS and Measurement (ICAP Annual Meeting 2007)APS and Measurement (ICAP Annual Meeting 2007)
APS and Measurement (ICAP Annual Meeting 2007)
 

Recently uploaded

💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
Sheetaleventcompany
 
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Sheetaleventcompany
 
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan CytotecJual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
jualobat34
 
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Sheetaleventcompany
 
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
Sheetaleventcompany
 
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
Sheetaleventcompany
 
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
Sheetaleventcompany
 
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Sheetaleventcompany
 

Recently uploaded (20)

🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
 
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
 
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
 
Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...
Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...
Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...
 
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
 
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
 
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan CytotecJual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
 
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
 
Intramuscular & Intravenous Injection.pptx
Intramuscular & Intravenous Injection.pptxIntramuscular & Intravenous Injection.pptx
Intramuscular & Intravenous Injection.pptx
 
❤️Call Girl Service In Chandigarh☎️9814379184☎️ Call Girl in Chandigarh☎️ Cha...
❤️Call Girl Service In Chandigarh☎️9814379184☎️ Call Girl in Chandigarh☎️ Cha...❤️Call Girl Service In Chandigarh☎️9814379184☎️ Call Girl in Chandigarh☎️ Cha...
❤️Call Girl Service In Chandigarh☎️9814379184☎️ Call Girl in Chandigarh☎️ Cha...
 
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
 
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service AvailableCall Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
 
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
 
Genuine Call Girls Hyderabad 9630942363 Book High Profile Call Girl in Hydera...
Genuine Call Girls Hyderabad 9630942363 Book High Profile Call Girl in Hydera...Genuine Call Girls Hyderabad 9630942363 Book High Profile Call Girl in Hydera...
Genuine Call Girls Hyderabad 9630942363 Book High Profile Call Girl in Hydera...
 
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
 
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
👉 Amritsar Call Girls 👉📞 8725944379 👉📞 Just📲 Call Ruhi Call Girl Near Me Amri...
 
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
 
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
 
Kolkata Call Girls Naktala 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Kolkata Call Girls Naktala  💯Call Us 🔝 8005736733 🔝 💃  Top Class Call Girl Se...Kolkata Call Girls Naktala  💯Call Us 🔝 8005736733 🔝 💃  Top Class Call Girl Se...
Kolkata Call Girls Naktala 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
 
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
 

Presentation: Results of National Adherence PHE

  • 1. National HIV Prevention , Care and Treatment Program Adherence Technical Meeting October 19 th - 22 nd , 2009 Jules Mugabo M.D HIV, AIDS and STI Unit TRAC Plus/ Rwanda MOH TRAC Plus C enter for T reatment and R esearch on A IDS, M alaria, T uberculosis and O ther E pidemics
  • 2.
  • 3. VCT National program 2004-2008 2004 2005 2006 2007 2008 Estimation of general population (census 2002) 8,577,753 8,814,253 9,058,392 9,309,619 9,567,190 Targeted population for VCT (50% of the general population) 4,288,877 4,407,127 4,529,196 4,654,810 4,783,595 % Of clients tested (denominator: Targeted population for VCT) 4.1% 10.2% 10.4% 16.1% 20.2% HIV seroprevalence in VCT 11.4% 9.4% 7.3% 4.8% 3.4% % of Health facilities offering VCT 26.5% 46.2% 51.8% 63.1% 75.4%
  • 4. PMTCT Program 2004-2008 2004 2005 2006 2007 2008 Rwanda population (census 2002) 8,577,753 8,814,253 9,058,392 9,309,619 9,567,190 Expected pregnant women 351,688 361,384 371,394 381,694 392,255 % of pregnant women tested for HIV 27% 49% 59% 56% 75% % of HIV + women receiving ART prophylaxis 35% 51% 60% 55% 67% % of exposed children receiving ART prophylaxis 26% 33% 46% 65% 63% % of partners tested for HIV in PMTCT ND 32,6% 52,4% 65% 78% % of discordant couples in PMTCT ND 4,5% 3,7% 3,1% 2,7% % of Health facilities providing PMTCT 26.5% 46.2% 51.8% 63.1% 75.4%
  • 5. Level of participation in PMTCT program
  • 6. Rate of MTCT of HIV
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12. ART Program 2004-2008 2004 2005 2006 2007 2008 Estimation of general population (census 2002) 8,577,753 8,814,253 9,058,392 9,309,619 9,567,190 Adults HIV+ adult (15+) 158,275 157,157 162,837 170,639 177,258 Adults in need of ARVs 50,106 48,733 49,316 52,949 92,421 Proportion of eligible adults receiving ART 18% 36% 64% 80% 62% Children HIV+ children (0-14) 29,373 29,621 29,878 30,275 31,299 Infants in need of ARVs 7,625 7,395 7,517 7,912 8,544 Proportion of eligible children receiving ART 7% 20% 37% 55% 66% Services coverage % of Health facilities offering 7% 18% 29% 36% 43%
  • 13. Patients on ART end June 2009 = 70,234 patients) ARV regimen % patients 96.58 % of adults patients D4T+3TC+NVP 48.07 AZT+3TC+NVP 34.82 D4T+3TC+EFV 5.40 AZT+3TC+EFV 8.29 Type of health facility Children Adults Hospital 37.3% 36.5% Health center 62.7% 63.5% Total 100%  100% 
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20. 100% self-reported adherence during 3 and 30 days
  • 21. Outcome: Self-reported adherence: 30-day recall N=575 N=490 N=352
  • 23. Timing of missed pills among patients reporting ≤100% adherence in 3 days preceding interview
  • 24. Most common reasons for ever missing ART
  • 25. Patient’s level factors predicting self-reported 30-day non-adherence …
  • 26. Patient’s level factors predicting self-reported 30-day non-adherence …
  • 27. Patient’s level factors predicting self-reported 30-day non-adherence …
  • 28. Facility level factors predicting self-reported 30-day non-adherence …
  • 29.
  • 30.
  • 31.